P.607 Esketamine nasal spray for rapid reduction of major...

European Neuropsychopharmacology 2019 / 12 Vol. 29

P.607 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: ASPIRE-2 study

Ionescu, D.F., Canuso, C.M., Fu, D.J., Qiu, X., Lane, R., Lim, P., Hough, D., Drevets, W., Manji, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
European Neuropsychopharmacology
DOI:
10.1016/j.euroneuro.2019.09.591
Date:
December, 2019
File:
PDF, 73 KB
2019
Conversion to is in progress
Conversion to is failed